NIH-funded research R01 grant

How arenaviruses’ defective particles help protect hosts and how our cells control them

Official title: The role of mammarenavirus defective interfering particles in protecting host fitness and the host-driven post-translational modifications that regulate their formation and function

Funded at University of Vermont & St Agric College · NIH-11398196 · Data updated 2026-11-12

This project studies how defective virus particles produced by arenaviruses influence infections and the body’s own cellular processes, with a focus on factors that regulate their formation and function in the host.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startAugust 19, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$598,271
NIH project number5R01AI171408-05
Project IDNIH-11398196 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient participation in this project; the work is conducted in cellular and animal models.

Less likely to help

Direct patient benefits are not expected from this basic-science grant, as no patient enrollment is described.

What this research studies

Researchers will explore how host cell enzymes and post-translational modifications govern the production of defective interfering particles by arenaviruses and how these particles affect host fitness and viral persistence in animal reservoirs. Using reverse genetics and advanced molecular tools, the team will map cellular pathways that distinguish normal virus production from defective particles and test how altering these pathways changes outcomes in infection models. The work aims to uncover mechanisms that could be leveraged to influence virus-host interactions and potentially limit zoonotic persistence. This is a basic science project, but it directly targets processes relevant to how arenaviruses interact with human and animal hosts.

Why it matters

Potential benefit: A deeper understanding of DIP regulation could inform future strategies to modulate virus behavior and host responses, potentially contributing to new approaches for managing arenavirus infections.

How similar studies have gone: Prior work has revealed distinct cellular pathways for DIP production; this proposal builds on those findings with new tools to map and manipulate host-DIP interactions.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Botten, Jason W. — University of Vermont & St Agric College
  • Study coordinator: Botten, Jason W.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.